Antibodies
8 January 2015
Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis8 January 2015
Dermira and UCB announce start of Phase 3 program for CIMZIA® (certolizumab pegol) in psoriasis5 January 2015
OncoMed Doses First Patient in Phase 1 Clinical Trial of Novel Anti-DLL4/VEGF Bispecific Antibody5 January 2015
Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets27 December 2014
First in the world regulatory approval of Novartis’ Cosentyx(TM) in Japan for both psoriasis and psoriatic arthritis23 December 2014
Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration19 December 2014
Roche provides update on gantenerumab development programme19 December 2014
First Phase II trial with IPH2201 open in head and neck cancer19 December 2014
Genentech Provides Update on Phase III MARIANNE Study in People with Previously Untreated Advanced HER2-Positive Breast Cancer17 December 2014
ABLYNX OPENS RECRUITMENT FOR FIRST-IN-INFANT PHASE IIa STUDY WITH ITS ANTI-RSV NANOBODY, ALX-017112 December 2014
Head-to-head psoriasis study demonstrates superiority of Novartis Cosentyx(TM) to Stelara® in clearing skin11 December 2014
Integral Molecular identifies potent inhibitory antibodies against Chikungunya virus10 December 2014
Angiochem Publishes Data On ANG4043, A Brain-Penetrant Anti-HER2 Monoclonal Antibody for Treatment of Brain Metastases9 December 2014
Vaccinex provides an update on its VX15/2503 Phase 1 clinical trial in cancer patients9 December 2014
Zydus Launches World’s First Biosimilar of AdalimumabNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports